Corporate Board Profile
Tech Score: 20/100
1 mention(s) identify MARIA PALASIS, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Lyra Therapeutics, Inc. | 2025-04-04 | Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine. | Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering and a postdoctoral fellowship in molecular biology, indicating strong technical and scientific background which likely includes programming or software-related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-14 | Maria Palasis, Ph.D. has served as our President and Chief Executive Officer and a member of our Board of Directors since January 2015. ... Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine. |
| 2022-04-27 | Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine. |
| 2023-04-25 | Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine. |
| 2024-04-29 | Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine. |
| 2025-04-04 | Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine. |
Data sourced from SEC filings. Last updated: 2026-03-05